PT  - JOURNAL ARTICLE
AU  - Assi, Rita
AU  - Hagag, Nabil
AU  - Farag, Sherif
AU  - Emmons, Robert
AU  - Carter, Allie
AU  - Czader, Magdalena
AU  - Abonnour, Rafat
AU  - Apetoh, Lionel
AU  - Ma, Yupo
AU  - Salman, Huda
TI  - 683 Phase I first-in-human study on the feasibility, safety, and antitumor activity of CD4-redirected chimeric antigen receptor (CAR) T-cell therapy in patients with CD4+ T-cell malignancies (TCM)
AID  - 10.1136/jitc-2023-SITC2023.0683
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A775--A776
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A775.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A775.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.